Manuela Raimondi is Full Professor of Bioengineering at Polytechnic University in Milan (since 2018), with over 25 years of research experience in industrial bioengineering. She holds a PhD in Bioengineering (2000) and an MSc in Mechanical Engineering (1993), both from Polytechnic University in Milan.
She has authored over 130 high-impact publications in journals such as PNAS, Trends in Molecular Medicine, Theranostics, Lab on a Chip, Advanced Optical Materials, and Advanced Functional Materials (impact factors ranging from 8 to 19). Her work includes pioneering technologies for biological research, including organ-on-a-chip platforms, 3D microscaffolds, and intravital imaging devices, with applications in oncology, neurodegeneration, immunology, and space medicine.
Raimondi is inventor on 9 international patents, granted across Europe, USA, China, Japan, and Australia, covering synthetic niches, millifluidic bioreactors, implantable imaging platforms, and pluripotency induction technologies.
She has secured and managed €7 million in competitive research funding, including 5 ERC grants. She is the first woman in Italy winner of and ERC Advanced grant in industrial engineering.
She founded MOAB Srl in 2019, serving as President and CSO, commercializing advanced cell culture platforms.
Raimondi has held institutional roles and she is a member of ITATEC, TERMIS, ESB, ESAO, and Founding President of ERC in Italy APS. She has served as grant evaluator for ERC, NSF, Swiss NSF, Irish RC, and others.
Her teaching portfolio includes over 10 courses across MSc, PhD, and BS programs in Biomedical Engineering, covering regenerative medicine, mechanobiology, and bioreactors.
She has delivered over 15 invited talks at international conferences including AAAS (2026), EOSAM (2024), ESB (2023), WCB (2022), TERMIS (multiple years), and SPIE.